PATENT CLAIM ANALYSIS

Application Number: 16270067
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["424", "250100"]

Abstract:
The present invention relates to Neisseria ORF2086 proteins, crossreactive immunogenic proteins which can be isolated from nesserial strains or prepared recombinantly, including immunogenic portions thereof, biological equivalents thereof, antibodies that immunospecifically bind to the foregoing and nucleic acid sequences encoding each of the foregoing, as well as the use of same in immunogenic compositions that are effective against infection by  Neisseria meningitidis  serogroup B.

Claim (Index 2):
The method according to  claim 1 , wherein the composition further comprises at least one protein comprising the amino acid sequence of any of even numbered SEQ ID NOS: 176-252.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.2963
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10492427', '13333123', '12408286', '13455268', '10652870']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7857028900293104
- 35 USC 102 Novelty (BERT): 0.6460251410273417
- Combined Prediction Score: 0.7717351151291135
- Mean Citation Score: 613.5319499999998
- Max Citation Score: 623.5239
- Similarity Product: 586.0259074133993

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test